| Market Capitalization (Millions $) |
0 |
| Shares
Outstanding (Millions) |
57 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
2 |
| Net Income (TTM) (Millions $) |
-1 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Acura Pharmaceuticals Inc. is a pharmaceutical company based in Illinois, United States. The company is focused on developing and commercializing innovative products that utilize their proprietary Aversion and Limitx technologies. These technologies aim to deter abuse and misuse of certain medications, particularly opioid pain medications.
Acura Pharmaceuticals has been actively collaborating with pharmaceutical companies to develop abuse-deterrent formulations of their existing products. Their collaborations have resulted in the development of products like Oxaydo, which is an immediate-release oxycodone tablet with abuse-deterrent properties.
The company also holds several issued and pending patents related to its Aversion and Limitx technologies. These patents provide Acura Pharmaceuticals with a competitive advantage in the market and drive their research and development efforts.
In addition to their pain medication products, Acura Pharmaceuticals is also engaged in the development of other prescription drugs and over-the-counter (OTC) medicines.
Overall, Acura Pharmaceuticals Inc. focuses on developing innovative technologies to deter abuse and misuse of medications, with the goal of improving patient safety and addressing the opioid crisis.
Company Address: 616 N. North Court, Suite 120, Palatine 60067 IL
Company Phone Number: 705 7709 Stock Exchange / Ticker: NASDAQ ACUR
|
0.000%